Predictive factors in head and neck cancer

Hematology/Oncology Clinics of North America

Volumn 13, Issue 4, 1999, Pages 777-785

  Bradford, C R ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLIN D1; FLUOROURACIL; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53;

APOPTOSIS; CANCER INVASION; CANCER STAGING; CELL CYCLE; GENE EXPRESSION; GENETIC MODEL; HEAD AND NECK CANCER; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; LARYNX CANCER; METASTASIS; ONCOGENE; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RADIOSENSITIVITY; REVIEW;

EID: 0032866684     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70092-7     Document Type: Article

References (43)

1. J. Akervall Y. Jin J. Wennerberg Chromosomal abnormalities involving 11q13 are associated with poor prognosis in squamous cell carcinoma of the head and neck Cancer 76 1995 853 859
2. Akervall J, Brun E, Michalides R, et al: Overexpression of cyclin D1 correlates with response to neoadjuvant treatment with cisplatin and 5-fluorouracil in squamous cell carcinoma of the head and neck. 1998, submitted
3. J.A. Akervall R. Michalides H. Mineta Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression Cancer 79 1997 380 389
4. L.H. Boise M. Gonzales-Garcia C.E. Postema Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptosic cell death Cell 74 1993 597 608
5. J. Bourhis G. Wilson P. Wibault Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer Laryngoscope 104 1994 468 472
6. Bradford CR, Wolf GT, Carey TE, et al: Predictive markers for response to chemotherapy, organ preservation and survival in patients with advanced laryngeal carcinoma. Otolarynol Head Neck Surg, in press
7. C.R. Bradford S. Zhu J. Poore p53 mutation as a prognostic marker in advanced laryngeal carcinoma Arch Otolaryngol Head Neck Surg 123 1997 605 609
8. C.R. Bradford S. Zhu G.T. Wolf Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer Otolaryngol Head Neck Surg 113 1995 408 412
9. J. Califano P. van der Riet W. Westra Genetic progression model for head and neck cancer: Implications for field cancerization Cancer Res 56 1996 2488 2492
10. S.K. Chiou L. Rao E. White Bcl-2 blocks p53-dependent apoptosis Mol Cell Biol 14 1994 2556 2563
11. I.W. Dimery A.M. Kramer A.J. Choksi Neoadjuvant chemotherapy and radiotherapy in larynx preservation Am J Clin Oncol 12 1989 173 177
12. C. Dive J.A. Hickman Drug-target interactions: Only the first step in the commitment to programmed cell death Br J Cancer 64 1991 192 196
13. C. Dive A.H. Wyllie Apoptosis and cancer chemotherapy J.S. Hickman T.R. Tritton Cancer Chemotherapy 1993 Blackwell Scientific Publications Oxford 21 56
14. M. Dole G. Nunez K. Andrea Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma Cancer Res 54 1994 3253 3259
15. A. Eastman Activation of programmed cell death by anticancer agents: Cisplatin as a model system Cancer Cells 2 1990 275 280
16. D. Fisher Apoptosis in cancer therapy: Crossing the threshold Cell 78 1994 539 542
17. C.M. Gregg T.E. Beals K.M. McClatchey DNA content and tumor response to induction chemotherapy in patients with advanced laryngeal squamous cell carcinoma Otolaryngol Head Neck Surg 108 1993 731 737
18. S. Haldar M. Negrini M. Monne Down-regulation of bcl-2 by p53 in breast cancer cells Cancer Res 54 1994 2095 2097
19. J.J.O. Herod A. Eliopoulos J. Warwick The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma Cancer Res 56 1996 2178 2184
20. J. Hickman Apoptosis induced by anticancer drugs Cancer Metastasis Rev 11 1992 121 139
21. C. Jacobs D.R. Goffinet L. Goffinet Chemotherapy as a substitute for surgery in the treatment of advanced resectable head and neck cancer Cancer 60 1987 1178 1183
22. P.A. Jakobsson Histologic classification and grading of malignancy in carcinoma of the larynx Acta Radiol 12 1973 1 8
23. J.T. Johnson E.N. Myers V.L. Schramm Adjuvant chemotherapy for high-risk squamous cell carcinoma of the head and neck J Clin Oncol 5 1987 456 458
24. J.W. Jones J.R. Raval T.F. Beals Frequent loss of heterozygosity on chromosome arm 18q in squamous cell carcinomas: Identification of two regions of loss–18q11.1–q12.3 and 18q21.1–q23 Arch Otolaryngol Head Neck Surg 123 1997 1 5
25. S. Kamesaki H. Kamesaki T. Jorgensen Bcl-protein inhibits etoposide-induced apoptosis through its effects on events subsequent to topoisomerase II–induced DNA strand breaks and their repair Cancer Res 53 1993 4251 4256
26. W.M. Koch J.A. Brennan M. Zahurak p53 mutation is associated with locoregional recurrence but not decreased survival in head and neck squamous cell carcinoma J Natl Cancer Inst 88 1996 1580 1586
27. J.L. Lefebvre D. Chevalier B. Luboinski Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group J Natl Cancer Inst 88 1996 890 899
28. J. Lotem L. Sachs Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents Blood 82 1993 1092 1096
29. J. Lotem L. Sachs Regulation of Bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compound in differentation competent and defective myeloid leukemia cells Cell Growth Differ 4 1993 41 47
30. T. Miyashita S. Krajewski M. Krajewska Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo Oncogene 9 1994 1799 1805
31. R.P. Pearlstein M.S. Benninger T.E. Carey Loss of 18q predicts poor survival of patients with squamous cell carcinoma of the head and neck Genes Chromosomes Cancer 21 1998 333 339
32. J.C. Reed Bcl-2 and the regulation of programmed cell death J Cell Bio 124 1994 1 6
33. J.C. Reed Regulation of chemoresistance by the Bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cells Ann Oncol 5 1994 61 65
34. A.F. Schott I. Apel G. Nunez Bcl-xl protects cancer cells from p53-mediated apoptosis Oncogene 11 1995 1389 1394
35. L can differentially block chemotherapy induced cell death Blood 90 1997 1208 1216
36. V.N. Sumantran M.W. Ealovega G. Nunez Overexpression of Bcl-xs sensitizes MCF-7 cells to chemotherapy-induced apoptosis Cancer Res 55 1995 2507 2510
37. M.B. Spaulding S.G. Fisher G.T. Wolf Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma J Clin Oncol 12 1994 1592 1599
38. J.M. Truelson S.G. Fisher T.E. Beals DNA content with histologic growth pattern correlate with prognosis in patients with advanced squamous cell carcinoma of the larynx Cancer 70 1992 56 62
39. S. Urba G.T. Wolf Organ preservation in multimodality therapy of head and neck cancer Hematol Oncol Clin North Am 5 1991 713 725
40. G.T. Wolf T.E. Carey Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma J Natl Cancer Inst Monogr 13 1992 67 74
41. G.T. Wolf W.K. Hong Induction chemotherapy for organ preservation in advanced laryngeal cancer: Is there a role? Head Neck 17 1995 279 283
42. G.T. Wolf W.K. Hong S. Fisher Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer N Engl J Med 394 1991 1685 1690
43. E. Yonish-Rouach D. Resnitsky Wild-type p53 induces apoptosis of myeloid leukemia cells that is inhibited by interleukin 2 Nature 352 1991 345 347